文献速递甲状腺疾病

通过研究TSC2条件性敲除小鼠模型界定mTORC1在甲状腺细胞中的体内作用

Defining the In Vivo Role of mTORC1 in Thyrocytes by Studying the TSC2 Conditional Knockout Mouse Model.
PubMed 文献 · Thyroid · 2024-05-08

研究采用甲状腺细胞特异性TSC2敲除小鼠模型使mTORC1功能获得,发现TPO-TSC2KO小鼠TSC2水平降低70-80%、mTORC1活性升高六倍,甲状腺快速增大并持续生长,甲状腺激素合成关键基因表达下调,雷帕霉素可阻止甲状腺质量扩张并恢复基因表达改变。

要点

  • TPO-TSC2KO小鼠TSC2水平降低70-80%,mTORC1活性升高六倍。
  • TPO-TSC2KO小鼠甲状腺快速增大并终生持续生长,滤泡增大、胶质和上皮面积增加。
  • TPO-TSC2KO小鼠甲状腺激素合成关键基因Tg、Tpo、Nis表达进行性下调,NIS蛋白表达减少。

核心结论

  • 甲状腺细胞特异性小鼠模型揭示mTORC1激活抑制甲状腺激素生物合成、抑制甲状腺细胞基因表达并促进生长和增殖。

研究设计与样本

  • 通过删除mTORC1细胞内抑制因子TSC2,构建甲状腺细胞mTORC1功能获得的新型小鼠模型。

主要发现

  • TPO-TSC2KO小鼠TSC2水平降低70-80%,mTORC1活性升高六倍。
  • 雄性和雌性TPO-TSC2KO小鼠甲状腺均快速增大并终生持续生长,滤泡更大,胶质和上皮面积增加。
  • TPO-TSC2KO小鼠Ki67染色显示甲状腺细胞增殖升高,cyclin D3表达升高。
  • mTORC1激活导致甲状腺激素生物合成关键基因Tg、Tpo和Nis进行性下调,而Tff1、Pax8和Mct8 mRNA水平未受影响;TPO-TSC2KO小鼠NIS蛋白表达也减少。
  • 雷帕霉素治疗阻止TPO-TSC2KO小鼠甲状腺质量扩张并恢复基因表达改变。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: The thyroid gland is susceptible to abnormal epithelial cell growth, often resulting in thyroid dysfunction. The serine-threonine protein kinase mechanistic target of rapamycin (mTOR) regulates cellular metabolism, proliferation, and growth through two different protein complexes, mTORC1 and mTORC2. The PI3K-Akt-mTORC1 pathway's overactivity is well associated with heightened aggressiveness in thyroid cancer, but recent studies indicate the involvement of mTORC2 as well. Methods: To elucidate mTORC1's role in thyrocytes, we developed a novel mouse model with mTORC1 gain of function in thyrocytes by deleting tuberous sclerosis complex 2 (TSC2), an intracellular inhibitor of mTORC1. Results: The resulting TPO-TSC2KO mice exhibited a 70-80% reduction in TSC2 levels, leading to a sixfold increase in mTORC1 activity. Thyroid glands of both male and female TPO-TSC2KO mice displayed rapid enlargement and continued growth throughout life, with larger follicles and increased colloid and epithelium areas. We observed elevated thyrocyte proliferation as indicated by Ki67 staining and elevated cyclin D3 expression in the TPO-TSC2KO mice. mTORC1 activation resulted in a progressive downregulation of key genes involved in thyroid hormone biosynthesis, including thyroglobulin (Tg), thyroid peroxidase (Tpo), and sodium-iodide symporter (Nis), while Tff1, Pax8, and Mct8 mRNA levels remained unaffected. NIS protein expression was also diminished in TPO-TSC2KO mice. Treatment with the mTORC1 inhibitor rapamycin prevented thyroid mass expansion and restored the gene expression alterations in TPO-TSC2KO mice. Although total thyroxine (T4), total triiodothyronine (T3), and TSH plasma levels were normal at 2 months of age, a slight decrease in T4 and an increase in TSH levels were observed at 6 and 12 months of age while T3 remained similar in TPO-TSC2KO compared with littermate control mice. Conclusions: Our thyrocyte-specific mouse model reveals that mTORC1 activation inhibits thyroid hormone (TH) biosynthesis, suppresses thyrocyte gene expression, and promotes growth and proliferation.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Rossetti CL, Alves BL, Peçanha FLM, et al. Defining the In Vivo Role of mTORC1 in Thyrocytes by Studying the TSC2 Conditional Knockout Mouse Model. Thyroid. 2024. PMID: 38661550. doi:10.1089/thy.2024.0053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。